Jiraphun Jittikoon
- Pharmacology top 5%
- Drug-Induced Adverse Reactions 6
- Drug-Induced Hepatotoxicity and Protection 5
- Pharmacogenetics and Drug Metabolism 4
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology 8
- COVID-19 Clinical Research Studies 4
-
- Drug-Induced Adverse Reactions 6
- Drug-Induced Hepatotoxicity and Protection 5
- Pharmacogenetics and Drug Metabolism 4
-
- Pneumocystis jirovecii pneumonia detection and treatment 6
-
- Drug Transport and Resistance Mechanisms 4
-
- Prenatal Screening and Diagnostics 4
- Co-authors
- Wanvisa UdomsinprasertUsa ChaikledkaewSittisak HonsawekSermsiri SangroongruangsriSurakameth MahasirimongkolSukanya WattanapokayakitNuanjun WichukchindaWasun Chantratita
- Journals
- Scientific Reports (9 papers)PLoS ONE (5 papers)ClinicoEconomics and Outcomes Research (3 papers)
- Partner nations
- ThailandUnited KingdomPhilippines
In The Last Decade
Jiraphun Jittikoon
47 papers receiving 605 citations
Peers
Comparison fields: 5 of 90
- Pharmacology 88
- Infectious Diseases 151
- Toxicology 16
- Pharmacology 76
- Neurology 68
Countries citing papers authored by Jiraphun Jittikoon
This map shows the geographic impact of Jiraphun Jittikoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiraphun Jittikoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiraphun Jittikoon more than expected).
Fields of papers citing papers by Jiraphun Jittikoon
This network shows the impact of papers produced by Jiraphun Jittikoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiraphun Jittikoon. The network helps show where Jiraphun Jittikoon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiraphun Jittikoon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 2 | |
| 12 | Cost-Utility Analysis of Molecular Testing for Tuberculosis Diagnosis in Suspected Pulmonary Tuberculosis in Thailand | 2022 | 7 |
| 13 | 2022 | 12 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 8 | |
| 17 | 2021 | 9 | |
| 18 | 2020 | 4 | |
| 19 | 2019 | 16 | |
| 20 | 2015 | 28 |
About Jiraphun Jittikoon
Jiraphun Jittikoon is a scholar working on Infectious Diseases, Pharmacology, Pediatrics, Perinatology and Child Health, Pharmacology and Microbiology, having authored 51 papers that have together received 614 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (8 papers), Drug-Induced Adverse Reactions (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), COVID-19 Clinical Research Studies (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Prenatal Screening and Diagnostics (4 papers). The work is most often cited by research in Pharmacology (88 citations), Infectious Diseases (151 citations), Toxicology (16 citations), Pharmacology (76 citations) and Neurology (68 citations). Jiraphun Jittikoon has collaborated with scholars based in Thailand, United Kingdom and Philippines. Frequent co-authors include Wanvisa Udomsinprasert, Usa Chaikledkaew, Sittisak Honsawek, Sermsiri Sangroongruangsri, Surakameth Mahasirimongkol, Sukanya Wattanapokayakit, Nuanjun Wichukchinda, Wasun Chantratita, Ammarin Thakkinstian and Abhasnee Sobhonslidsuk. Their work appears in journals such as Scientific Reports, PLoS ONE, ClinicoEconomics and Outcomes Research, Cartilage and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.